|1.||Kang, Kyung A: 3 articles (01/2013 - 01/2008)|
|2.||Stodieck, Louis S: 2 articles (10/2013 - 01/2013)|
|3.||Jones, Tamako A: 2 articles (10/2013 - 01/2013)|
|4.||Ferguson, Virginia L: 2 articles (10/2013 - 01/2013)|
|5.||Bateman, Ted A: 2 articles (10/2013 - 01/2013)|
|6.||Pecaut, Michael J: 2 articles (10/2013 - 01/2013)|
|7.||Moldovan, Maria: 2 articles (10/2013 - 01/2013)|
|8.||Gridley, Daila S: 2 articles (10/2013 - 01/2013)|
|9.||Cunningham, Christopher E: 2 articles (10/2013 - 01/2013)|
|10.||Beran, Roy G: 2 articles (04/2008 - 12/2006)|
|1.||Myocardial Ischemia (Ischemic Heart Diseases)
07/01/1991 - "The purpose of this study was to compare the efficacy of three standard antianginal agents, nitrate, Ca antagonist, and beta blocker on myocardial ischemia in patients with effort angina (EA) using ambulatory electrocardiographic monitoring (AEM). "
07/01/1997 - "The purpose of this study was to assess whether the severity of myocardial ischemia would be attenuated by repeated daily ischemic episodes, recorded by ambulatory electrocardiographic monitoring (AEM). "
11/01/1990 - "The purpose of this study was to clarify the clinical and prognostic significance of silent myocardial ischemia (SMI) in patients with proven ischemic heart disease using ambulatory electrocardiographic monitoring (AEM). "
07/01/2001 - "Ambulatory ECG monitoring (AEM) is the only available method to assess the presence and severity of myocardial ischemia during daily life. "
11/01/1995 - "Myocardial ischemia was diagnosed by the presence of ST-segment depression occurring during AEM or ExT 4 +/- 2 and 7 +/- 4 days after hospital admission respectively. "
12/01/2014 - "This article was developed by the cardiovascular workgroup at the 2014 Academic Emergency Medicine (AEM) consensus conference to identify sex- and gender-specific gaps in the key themes and research questions related to emergency cardiac ischemia care. "
07/01/2001 - "In addition to increased demand, which is a major contributor to AEM detected-ischemia, increased coronary tone also seems to play a major role. "
07/01/2001 - "For this reason, and because of the high day-to-day variability in daily ischemic changes, AEM cannot be used as a screening tool for detecting CAD or for evaluating severity of ischemia in individual patients. "
07/01/1997 - "The inferior AEM lead detected ischemia in only 4 patients, while the aVF lead of the 12-lead ECG detected ischemia in 23 patients. "
07/01/1997 - "The best lead for ischemia detection with AEM was the V5 type, which detected ischemic changes in 26 of the 29 patients, while the 12-lead V5 detected ischemia in 24 patients. "
|3.||Atopic Dermatitis (Atopic Eczema)
01/01/2008 - "A randomized, double-blind study designed to compare the efficacy of DermaSilk versus a sleeve of similar structure but minus the AEM 5772/5 antimicrobial finish in the treatment of atopic dermatitis (AD). "
01/01/2008 - "The use of the antimicrobial AEM 5772/5, which does not transfer to the skin of the patient, is a new development in the control of atopic dermatitis. "
01/01/2008 - "This study demonstrates the importance of including the AEM 5772/5 finish to the specially knitted silk for a long-term improvement of atopic eczema symptoms."
06/01/2007 - "The use of Dermasilk has a significant beneficial effect in atopic dermatitis because of the non-irritating properties of silk as well as the antibacterial capacity of AEGIS AEM 5772/5."
01/01/2008 - "Published studies suggest that a specially treated silk material (DermaSilk), which is loosely knitted, has had the sericin removed and has a microbial agent (AEM 5772/5) permanently bonded to it, is well tolerated and has beneficial effects on the skin of children and adults with atopic dermatitis. "
01/01/2015 - "Epilepsy and AEM use are both associated with increased SCD risk in the general population. "
01/01/2015 - "AEM use was found in 23 cases and was associated with an increased SCD risk (cases 2.5%, controls 0.8%; adjusted OR overall 2.6, 95% CI 1.5 to 4.3) among symptomatic epilepsy cases (cases 0.9%, controls 0.1%; adjusted OR 6.4, 95% CI 2.4 to 17.4) and non-epilepsy cases (cases 1.0%, controls 0.4%; adjusted OR 2.3, 95% CI 1.01 to 5.2). "
12/01/2006 - "Competing influences of AEM and epilepsy-specific factors need delineation although appear more teratogenetic than does epilepsy alone. "
08/01/1997 - "This dual approach to care provided a real advantage to the management of patients with the dual diagnoses of OSA and epilepsy, which was refractory to standard AEM therapy."
07/01/1996 - "It was concluded that LTG is a relatively safe and effective AEM for certain patients with epilepsy who have proven refractory to the older AEMs. "
|5.||HIV Infections (HIV Infection)
01/01/2013 - "the Asian epidemic model (AEM) and resource needs model (RNM) were used to calculate incremental costs per HIV infection averted and per disability-adjusted life years saved (DALYs). "
10/01/2012 - "The AEM was used to estimate HIV infection under four different scenarios: (1) condom use among MSM maintained at the 2005 level, (2) condom use among MSM improved since 2005, (3) the sexually transmitted infection (STI) prevalence rate among MSM maintained at the 2008 level, and (4) the STI prevalence rate among MSM improved since 2008. "
|4.||Gonadotropin-Releasing Hormone (GnRH)
|8.||Lennox-Gastaut type Epileptic encephalopathy
|2.||Continuous Positive Airway Pressure